Krebs Biochemicals & Industries Ltd

NSE
KREBSBIO •
BUY

1W Return

-%

1M Return

-%

6M Return

-%

1Y Return

-%

3Y Return

-%

Start SIP in Krebs Biochemicals & Industries Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
43.34% Gain from 52W Low
-11.5
TTM PE Ratio
Negative PE TTM
-7.5
Price to Book Ratio
Negative Price to Book
-1.6
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-0.3
RSI
RSI is mid-range
44.2
MFI
MFI is mid-range
49.4

Krebs Biochemicals & Industries Ltd shareholding Pattern

Promoter
72.7%
Foreign Institutions
0.5%
Public
26.8%

Krebs Biochemicals & Industries Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
1
Bearish Moving Averages
15
5Day EMA
72.60
10Day EMA
72.90
12Day EMA
73.10
20Day EMA
73.60
26Day EMA
74.00
50Day EMA
75.10
100Day EMA
75.40
200Day EMA
77.40
Delivery & Volume
Resistance & Support
73.17
Pivot
Resistance
First Resistance
74.28
Second Resistance
75.97
Third Resistance
77.08
Support
First Support
71.48
Second support
70.37
Third Support
68.68
Relative Strength Index
44.24
Money Flow Index
49.43
MACD
-0.96
MACD Signal
-0.97
Average True Range
3.20
Average Directional Index
8.94
Rate of Change (21)
-4.41
Rate of Change (125)
3.12

Krebs Biochemicals & Industries Ltd Company background

Founded in: 1991
Managing director: Jitendra Shah
Krebs Biochemicals Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same.Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry. Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies.KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. During 200102, the company launched Vitamin C(I P Grade) through Fermentation Process. The Company commissioned 2.5 MW Cogeneration Power Plant at Unit II in Vizag during 200304 and started operations on it from July, 2004 onwards.
Read More

Krebs Biochemicals & Industries Ltd FAQs

Krebs Biochemicals & Industries Ltd shares are currently priced at 72.6 on NSE and 72.31 on BSE as of 2/27/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Krebs Biochemicals & Industries Ltd [KREBSBIO] share was 7.39. The Krebs Biochemicals & Industries Ltd [KREBSBIO] share hit a 1-year low of Rs. 50.65 and a 1-year high of Rs. 93.95.

The market cap of Krebs Biochemicals & Industries Ltd is Rs. 156.53 Cr. as of 2/27/2024 12:00:00 AM.

The PE ratios of Krebs Biochemicals & Industries Ltd is 0 as of 2/27/2024 12:00:00 AM.

The PB ratios of Krebs Biochemicals & Industries Ltd is -1.43 as of 2/27/2024 12:00:00 AM

You can easily buy Krebs Biochemicals & Industries Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage